Ingredients
Supplements And Ingredients You Can Trust
Iron
Peptides:
Overview:
GLP-1 receptor agonists are one of the most significant advances in metabolic research over the past decade. These peptides help regulate appetite, improve satiety, slow gastric emptying, and support healthy glucose metabolism, making them valuable tools in obesity and metabolic research.
The category has evolved through three major generations. Semaglutide is a GLP-1 receptor agonist and represents the first major breakthrough in modern peptide-based weight management. Tirzepatide is a dual GIP/GLP-1 receptor agonist, offering greater metabolic effects and, in clinical studies, improved average weight reduction compared with earlier GLP-1 therapies. Retatrutide is considered a next-generation triple agonist, targeting GLP-1, GIP, and glucagon receptors simultaneously.
Magnesium
Peptides:
Overview:
GLP-1 receptor agonists are one of the most significant advances in metabolic research over the past decade. These peptides help regulate appetite, improve satiety, slow gastric emptying, and support healthy glucose metabolism, making them valuable tools in obesity and metabolic research.
The category has evolved through three major generations. Semaglutide is a GLP-1 receptor agonist and represents the first major breakthrough in modern peptide-based weight management. Tirzepatide is a dual GIP/GLP-1 receptor agonist, offering greater metabolic effects and, in clinical studies, improved average weight reduction compared with earlier GLP-1 therapies. Retatrutide is considered a next-generation triple agonist, targeting GLP-1, GIP, and glucagon receptors simultaneously.
Omega 3
Peptides:
Overview:
GLP-1 receptor agonists are one of the most significant advances in metabolic research over the past decade. These peptides help regulate appetite, improve satiety, slow gastric emptying, and support healthy glucose metabolism, making them valuable tools in obesity and metabolic research.
The category has evolved through three major generations. Semaglutide is a GLP-1 receptor agonist and represents the first major breakthrough in modern peptide-based weight management. Tirzepatide is a dual GIP/GLP-1 receptor agonist, offering greater metabolic effects and, in clinical studies, improved average weight reduction compared with earlier GLP-1 therapies. Retatrutide is considered a next-generation triple agonist, targeting GLP-1, GIP, and glucagon receptors simultaneously.
Postbiotics
Peptides:
Overview:
GLP-1 receptor agonists are one of the most significant advances in metabolic research over the past decade. These peptides help regulate appetite, improve satiety, slow gastric emptying, and support healthy glucose metabolism, making them valuable tools in obesity and metabolic research.
The category has evolved through three major generations. Semaglutide is a GLP-1 receptor agonist and represents the first major breakthrough in modern peptide-based weight management. Tirzepatide is a dual GIP/GLP-1 receptor agonist, offering greater metabolic effects and, in clinical studies, improved average weight reduction compared with earlier GLP-1 therapies. Retatrutide is considered a next-generation triple agonist, targeting GLP-1, GIP, and glucagon receptors simultaneously.
Probiotics
Peptides:
Overview:
GLP-1 receptor agonists are one of the most significant advances in metabolic research over the past decade. These peptides help regulate appetite, improve satiety, slow gastric emptying, and support healthy glucose metabolism, making them valuable tools in obesity and metabolic research.
The category has evolved through three major generations. Semaglutide is a GLP-1 receptor agonist and represents the first major breakthrough in modern peptide-based weight management. Tirzepatide is a dual GIP/GLP-1 receptor agonist, offering greater metabolic effects and, in clinical studies, improved average weight reduction compared with earlier GLP-1 therapies. Retatrutide is considered a next-generation triple agonist, targeting GLP-1, GIP, and glucagon receptors simultaneously.
Vitamin A
Peptides:
Overview:
GLP-1 receptor agonists are one of the most significant advances in metabolic research over the past decade. These peptides help regulate appetite, improve satiety, slow gastric emptying, and support healthy glucose metabolism, making them valuable tools in obesity and metabolic research.
The category has evolved through three major generations. Semaglutide is a GLP-1 receptor agonist and represents the first major breakthrough in modern peptide-based weight management. Tirzepatide is a dual GIP/GLP-1 receptor agonist, offering greater metabolic effects and, in clinical studies, improved average weight reduction compared with earlier GLP-1 therapies. Retatrutide is considered a next-generation triple agonist, targeting GLP-1, GIP, and glucagon receptors simultaneously.
Vitamin B12
Peptides:
Overview:
GLP-1 receptor agonists are one of the most significant advances in metabolic research over the past decade. These peptides help regulate appetite, improve satiety, slow gastric emptying, and support healthy glucose metabolism, making them valuable tools in obesity and metabolic research.
The category has evolved through three major generations. Semaglutide is a GLP-1 receptor agonist and represents the first major breakthrough in modern peptide-based weight management. Tirzepatide is a dual GIP/GLP-1 receptor agonist, offering greater metabolic effects and, in clinical studies, improved average weight reduction compared with earlier GLP-1 therapies. Retatrutide is considered a next-generation triple agonist, targeting GLP-1, GIP, and glucagon receptors simultaneously.
Vitamin C
Peptides:
Overview:
GLP-1 receptor agonists are one of the most significant advances in metabolic research over the past decade. These peptides help regulate appetite, improve satiety, slow gastric emptying, and support healthy glucose metabolism, making them valuable tools in obesity and metabolic research.
The category has evolved through three major generations. Semaglutide is a GLP-1 receptor agonist and represents the first major breakthrough in modern peptide-based weight management. Tirzepatide is a dual GIP/GLP-1 receptor agonist, offering greater metabolic effects and, in clinical studies, improved average weight reduction compared with earlier GLP-1 therapies. Retatrutide is considered a next-generation triple agonist, targeting GLP-1, GIP, and glucagon receptors simultaneously.
Zinc
Peptides:
Overview:
GLP-1 receptor agonists are one of the most significant advances in metabolic research over the past decade. These peptides help regulate appetite, improve satiety, slow gastric emptying, and support healthy glucose metabolism, making them valuable tools in obesity and metabolic research.
The category has evolved through three major generations. Semaglutide is a GLP-1 receptor agonist and represents the first major breakthrough in modern peptide-based weight management. Tirzepatide is a dual GIP/GLP-1 receptor agonist, offering greater metabolic effects and, in clinical studies, improved average weight reduction compared with earlier GLP-1 therapies. Retatrutide is considered a next-generation triple agonist, targeting GLP-1, GIP, and glucagon receptors simultaneously.